{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:56:39Z","timestamp":1792378599944,"version":"4.4.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Smoking in pregnancy is a substantial public health issue, but, apart from nicotine replacement therapy (NRT), pharmacological therapies are not generally used to promote cessation. Bupropion and varenicline are effective cessation methods in nonpregnant smokers and this systematic review investigates their safety in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched MEDLINE, EMBASE, CINAHL, and PsychINFO databases for studies of any design reporting pregnancy outcomes after bupropion or varenicline exposure. We included studies of bupropion used for smoking cessation, depression, or where the indication was unspecified. Depending on study design, quality was assessed using the Newcastle-Ottawa Scale or Cochrane Risk of Bias Tool. Most findings are reported narratively but meta-analyses were used to produce pooled estimates for the proportion of live births with congenital malformations and of the mean birthweight and gestational age at delivery following bupropion exposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 18 studies were included: 2 randomized controlled trials, 11 cohorts, 2 case\u2013 control studies, and 3 case reports. Study quality was variable. Gestational safety outcomes were reported in 14 bupropion and 4 varenicline studies. Meaningful meta-analysis was only possible for bupropion exposure, for which the pooled estimated proportion of congenital malformations amongst live-born infants was 1.0% (95% CI = 0.0%\u20133.0%, I2 = 80.9%, 4 studies) and the mean birthweight and mean gestational age at delivery was 3305.9 g (95% CI = 3173.2\u20133438.7 g, I2 = 77.6%, 5 studies) and 39.2 weeks (95% CI = 38.8\u201339.6 weeks, I2 = 69.9%, 5 studies), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There was no strong evidence that either major positive or negative outcomes were associated with gestational use of bupropion or varenicline. PROSPERO registration number CRD42017067064.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications<\/jats:title><jats:p>We believe this to be the first systematic review investigating the safety of bupropion and varenicline in pregnancy. Meta-analysis of outcomes following bupropion exposure in pregnancy suggests that there are no major positive or negative impacts on the rate of congenital abnormalities, birthweight, or premature birth. Overall, we found no evidence that either of these treatments might be harmful in pregnancy, and no strong evidence to suggest safety, but available evidence is of poor quality.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ntr\/nty055","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T04:10:53Z","timestamp":1521691853000},"page":"1001-1010","source":"Crossref","is-referenced-by-count":70,"title":["Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-6713","authenticated-orcid":false,"given":"Emily","family":"Turner","sequence":"first","affiliation":[{"name":"Division of Primary Care, University Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jones","sequence":"first","affiliation":[{"name":"Division of Primary Care, University Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R","family":"Vaz","sequence":"first","affiliation":[{"name":"Division of Primary Care, University Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Coleman","sequence":"first","affiliation":[{"name":"Division of Primary Care, University Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"issue":"4","key":"2020041613253298900_CIT0001","first-page":"352","article-title":"Smoking and the young - summary of a report of a working party of the Royal College of Physicians","volume":"26","author":"Clarke","year":"1992","journal-title":"J R Coll Physicians of Lond"},{"issue":"1","key":"2020041613253298900_CIT0002","first-page":"1","article-title":"Smoking prevalence and cessation before and during pregnancy: Data from the birth certificate, 2014","volume":"65","author":"Curtin","year":"2016","journal-title":"Natl Vital Stat Rep"},{"issue":"1","key":"2020041613253298900_CIT0003","doi-asserted-by":"crossref","first-page":"e84640","DOI":"10.1371\/journal.pone.0084640","article-title":"Smoking during pregnancy: Findings from the 2009-2010 Canadian Community Health Survey","volume":"9","author":"Cui","year":"2014","journal-title":"PLoS One"},{"key":"2020041613253298900_CIT0004","volume-title":"Infant Feeding Survey 2010","author":"McAndrew","year":"2012"},{"issue":"10","key":"2020041613253298900_CIT0005","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thx.2010.153379","article-title":"Exposure to parental and sibling smoking and the risk of smoking uptake in childhood and adolescence: a systematic review and meta-analysis","volume":"66","author":"Leonardi-Bee","year":"2011","journal-title":"Thorax"},{"issue":"5","key":"2020041613253298900_CIT0006","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/14622200500262840","article-title":"Longitudinal analysis of the effect of prenatal nicotine exposure on subsequent smoking behavior of offspring","volume":"7","author":"Roberts","year":"2005","journal-title":"Nicotine Tob Res"},{"key":"2020041613253298900_CIT0007","volume-title":"Estimating the Costs to the NHS of Smoking in Pregnancy for Pregnant Women and Infants","author":"Godfrey","year":"2010"},{"issue":"2","key":"2020041613253298900_CIT0008","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1524-4733.2007.00240.x","article-title":"Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: A randomized controlled trial","volume":"11","author":"Ruger","year":"2008","journal-title":"Value Health"},{"issue":"626","key":"2020041613253298900_CIT0009","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.3399\/bjgp14X681361","article-title":"Prescribing of nicotine replacement therapy in and around pregnancy: A population-based study using primary care data","volume":"64","author":"Dhalwani","year":"2014","journal-title":"Br J Gen Pract"},{"issue":"12","key":"2020041613253298900_CIT0010","first-page":"CD010078","article-title":"Pharmacological interventions for promoting smoking cessation during pregnancy","author":"Coleman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2020041613253298900_CIT0011","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/ntr\/ntw080","article-title":"The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: A secondary analysis of a randomized controlled trial","volume":"18","author":"Vaz","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"10","key":"2020041613253298900_CIT0012","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2213-2600(15)00320-3","article-title":"Cardiovascular and neuropsychiatric risks of varenicline: A retrospective cohort study","volume":"3","author":"Kotz","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"4","key":"2020041613253298900_CIT0013","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub6","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"18","author":"Cahill","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020041613253298900_CIT0014","volume-title":"Champix: EPAR - Scientific Discussion","author":"Agency EM","year":"2006"},{"key":"2020041613253298900_CIT0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1471-2458-6-300","article-title":"Effectiveness of smoking cessation therapies: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2006","journal-title":"BMC Public Health"},{"key":"2020041613253298900_CIT0016","first-page":"CRD42017067064","article-title":"A systematic review to assess the safety of drug treatments which are used rarely for smoking cessation in pregnancy: Dual nicotine replacement therapy, varenicline and bupropion","author":"Turner","year":"2017","journal-title":"PROSPERO"},{"issue":"7","key":"2020041613253298900_CIT0017","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"2020041613253298900_CIT0018","author":"Wells"},{"key":"2020041613253298900_CIT0019","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2020041613253298900_CIT0020","article-title":"Stata Statistical Software: Release 14. College Station, TX: StataCorp LP","author":"StataCorp","year":"2015"},{"issue":"3","key":"2020041613253298900_CIT0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"4","key":"2020041613253298900_CIT0022","doi-asserted-by":"crossref","first-page":"420.e1","DOI":"10.1016\/j.ajog.2016.11.1036","article-title":"Bupropion sustained release for pregnant smokers: A randomized, placebo-controlled trial","volume":"216","author":"Nanovskaya","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2020041613253298900_CIT0023","first-page":"351","article-title":"Randomized, controlled pilot trial of bupropion for pregnant smokers: Challenges and future directions","volume":"32","author":"Stotts","year":"2015","journal-title":"Am J Perinatol"},{"issue":"5","key":"2020041613253298900_CIT0024","doi-asserted-by":"crossref","first-page":"611.e1","DOI":"10.1016\/j.ajog.2016.06.059","article-title":"Success of smoking cessation interventions during pregnancy","volume":"215","author":"B\u00e9rard","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"2020041613253298900_CIT0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00228-003-0693-0","article-title":"Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000","volume":"59","author":"Boshier","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2020041613253298900_CIT0026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v24n02_02","article-title":"Effectiveness of bupropion for smoking cessation during pregnancy","volume":"24","author":"Chan","year":"2005","journal-title":"J Addict Dis"},{"issue":"3","key":"2020041613253298900_CIT0027","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2020041613253298900_CIT0028","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pds.1296","article-title":"Bupropion in pregnancy and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2020041613253298900_CIT0029","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can J Psychiatry"},{"key":"2020041613253298900_CIT0030","volume-title":"The Bupropion Pregnancy Registry: Final Report","author":"GlaxoSmithKline","year":"2008"},{"issue":"5","key":"2020041613253298900_CIT0031","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","article-title":"Antidepressant use and risk for preeclampsia","volume":"24","author":"Palmsten","year":"2013","journal-title":"Epidemiology"},{"issue":"10","key":"2020041613253298900_CIT0032","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.3489","article-title":"Exposure to the smoking cessation medicine varenicline during pregnancy: A prospective nationwide cohort study","volume":"22","author":"Harrison-Woolrych","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020041613253298900_CIT0033","first-page":"244","article-title":"Maternal use of varenicline and risk of congenital malformations","volume":"24","author":"Olsen","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020041613253298900_CIT0034","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.reprotox.2016.11.010","article-title":"Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services","volume":"67","author":"Richardson","year":"2017","journal-title":"Reprod Toxicol"},{"issue":"1","key":"2020041613253298900_CIT0035","doi-asserted-by":"crossref","first-page":"52.e1","DOI":"10.1016\/j.ajog.2010.02.015","article-title":"Maternal use of bupropion and risk for congenital heart defects","volume":"203","author":"Alwan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"2020041613253298900_CIT0036","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pds.3661","article-title":"First-trimester exposure to bupropion and risk of cardiac malformations","volume":"23","author":"Louik","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9-10","key":"2020041613253298900_CIT0037","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1515\/JPEM.2011.317","article-title":"Hyperinsulinism associated with gestational exposure to bupropion in a newborn infant","volume":"24","author":"Gisslen","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"2020041613253298900_CIT0038","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/00016349.2010.485632","article-title":"Fetal cardiac arrhythmia during bupropion use","volume":"89","author":"Leventhal","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2020041613253298900_CIT0039","first-page":"263981","article-title":"Pregnancy outcome after varenicline exposure in the first trimester","volume":"2014","author":"Kaplan","year":"2014","journal-title":"Case Rep Obstet Gynecol"},{"issue":"8","key":"2020041613253298900_CIT0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/bdra.23384","article-title":"The National Birth Defects Prevention Study: A review of the methods","volume":"103","author":"Reefhuis","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2020041613253298900_CIT0041","author":"EESoC"},{"key":"2020041613253298900_CIT0042","author":"EESoC"},{"issue":"2","key":"2020041613253298900_CIT0043","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/bdra.20351","article-title":"Metropolitan atlanta congenital defects program: Executive summary","volume":"79","author":"Program MACD","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2 Pt 1","key":"2020041613253298900_CIT0044","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/AOG.0b013e3181cbd5f5","article-title":"Trends in birth weight and gestational length among singleton term births in the United States: 1990-2005","volume":"115","author":"Donahue","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2020041613253298900_CIT0045","author":"Statistics Canada CVS"},{"issue":"8","key":"2020041613253298900_CIT0046","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-0528.1996.tb09878.x","article-title":"Smoking during pregnancy: The dose dependence of birthweight deficits","volume":"103","author":"Ellard","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"2020041613253298900_CIT0047","doi-asserted-by":"crossref","first-page":"e003692","DOI":"10.1136\/bmjopen-2013-003692","article-title":"The Smoking MUMS (Maternal Use of Medications and Safety) Study: protocol for a population-based cohort study using linked administrative data","volume":"3","author":"Havard","year":"2013","journal-title":"BMJ Open"},{"key":"2020041613253298900_CIT0048","author":"Kranzler"},{"key":"2020041613253298900_CIT0049","author":"Miller"},{"key":"2020041613253298900_CIT0050","author":"Pfizer"}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/21\/8\/1001\/33095154\/nty055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/21\/8\/1001\/33095154\/nty055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T22:51:24Z","timestamp":1604011884000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/21\/8\/1001\/4951455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,3,22]]},"published-print":{"date-parts":[[2019,7,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/nty055","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2018,3,22]]}}}